Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Controlled Trial
JAMA Psychiatry 2023 Dec 06;[EPub Ahead of Print], ST Aaronson, A van der Vaart, T Miller, J LaPratt, K Swartz, A Shoultz, M Lauterbach, HA Sackeim, T SuppesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.